VEDA TRIALS
LIVE

Serial Number

98091041

Owner

RH Studio 2 OpCo 53, Inc

Attorney

ELIZABETH OLINER

Filing Date

Jul 18, 2023

Add to watchlist:

No watchlists yet
View on USPTO

VEDA TRIALS Trademark

Serial Number: 98091041

VEDA TRIALS is a trademark filed by RH Studio 2 OpCo 53, Inc on July 18, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

RH Studio 2 OpCo 53, Inc (3 trademarks)

8th Floor 85 Fifth Avenue
New York, NY 10003

Entity Type: 03

VEDA LIFE SCIENCES, INC.

867 BOYLSTON ST., 5TH FLOOR #2054
BOSTON, MA 02116

Entity Type: 03

Trademark Details

Filing Date

July 18, 2023

Registration Date

Not Registered

Published for Opposition

November 12, 2024

Goods & Services

Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Platform as a service (PAAS) featuring computer software platforms for use in running, managing and analyzing clinical trials, namely, enabling providers to create and scale clinical research capabilities and bring scientific advancements to patients that need them most; Platform as a service (PAAS) featuring computer software platforms for use in managing and participating in clinical research and view data analytics, enabling site data capture, selecting configurable data collection methods with configurable options and configuring a participant-facing website to recruit and screen participants for eligibility; Platform as a service (PAAS) featuring computer software platforms for use in bringing trained clinical research coordinators together with community managers to run clinical trials at scale; Providing a website featuring non-downloadable software for use in clinical research analytics, data capture forms, electronic clinical outcome assessments (eCOA), recruitment, and electronic consent; Providing a website featuring non-downloadable software for enabling users to manage and participate in clinical research, view data analytics, enable site data capture, and screen participants for eligibility; Providing information in the field of clinical research via a website; Providing scientific research information in the field of clinical trials; none of the foregoing comprised of or consisting of the provision of healthcare or telehealth services, scheduling healthcare or telehealth appointments, or allowing a patient to access personal healthcare information for the provision of healthcare or telehealth services

Filing History

STATEMENT OF USE PROCESSING COMPLETE
Jun 8, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 7, 2026 AITU
USE AMENDMENT FILED
Feb 18, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 18, 2026 EISU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 30, 2025 ASGN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 30, 2025 NOAM
TTAB RELEASE CASE TO TRADEMARKS
Nov 13, 2025 TMBN
OPPOSITION TERMINATED NO. 999999
Nov 13, 2025 OP.T
OPPOSITION DISMISSED NO. 999999
Nov 13, 2025 OP.D
OPPOSITION INSTITUTED NO. 999999
Jul 3, 2025 OP.I
CASE ASSIGNED TO TTAB
Jul 2, 2025 TTBN
NOTICE OF ALLOWANCE CANCELLED
Jul 2, 2025 IUCN
OPPOSITION PAPERS RECEIVED AT TTAB
Jul 2, 2025 OPPF
PETITION TO DIRECTOR GRANTED
Jul 1, 2025 PCGR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 1, 2025 NOAM
TEAS RESPONSE TO PETITION INQUIRY LETTER
Jun 27, 2025 ERTI
PETITION INQUIRY LETTER ISSUED
Jun 10, 2025 PILM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
May 22, 2025 ETOP
ASSIGNED TO PETITION STAFF
May 20, 2025 APET
PETITION TO DIRECTOR RECEIVED
May 12, 2025 PCRC
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 12, 2024 ETOF
LETTER OF PROTEST EVIDENCE FORWARDED
Nov 13, 2024 LOPT
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 12, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 23, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 30, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 30, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 30, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 30, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 30, 2024 CNEA
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Sep 30, 2024 LOPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 28, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 28, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 28, 2024 TROA
LETTER OF PROTEST EVIDENCE FORWARDED
Jun 7, 2024 LOPT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 24, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 24, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 24, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 22, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 17, 2023 NWOS
NEW APPLICATION ENTERED
Jul 21, 2023 NWAP